Seminars in Oncology
Издатель: Elsevier · ISSN 0093-7754 · 27 статей
- Immune Suppression and Infection Control in Cancer Patients: Clinical Management Challenges and Emerging Strategies
- Divergent Incidence and Mortality Trends in Early-Onset Colorectal Cancer in the United States, 1992–2023: An Age–Period–Cohort Analysis
- Plasma lipid species and breast cancer phenotypes: a two-sample Mendelian randomization analysis with multiplicity and sensitivity assessment
- Interplay of Oncogenic Pathways in Colorectal Cancer: Mechanisms Driving Progression and Drug Resistance
- Masthead
- Editorial Board
- Table of Contents
- Tumour immunotherapy in solid and hematologic malignancies: Progress, challenges, and a practical framework
- Single-cell sequencing in pan-cancer research: Decoding heterogeneity, tumor microenvironment, and clinical translation
- Integrating patient-reported outcomes into explainable machine learning models for long-term survival prediction in TKI-treated metastatic renal cell carcinoma
- The role of fumarate and itaconate in tumor microenvironment
- Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons
- SPIB as a context–specific regulator in cancer: from molecular mechanisms to clinical implications
- Bone metastasis in cancer: from microenvironmental remodeling to precision therapy
- Microbiome oncolytic virus interactions in cancer: emerging evidence and therapeutic implications for immunotherapy
- Immunotherapy in multiple myeloma: Molecular mechanisms, current clinical strategies, resistance, and future perspectives
- Oncolytic viruses in gastrointestinal malignancies: Clinical progress, translational challenges, and future directions
- Mutation-associated cGAS-STING signaling and the co-evolution of the tumor immune microenvironment in DNA damage repair-deficient tumors: from spatial architecture to bedside translation
- NK3 subsets are linked to NK cell exhaustion and immunotherapy responsiveness in tumor
- Early hepatic decompensation is associated with mortality in patients with HCC treated with atezolizumab plus bevacizumab or durvalumab plus tremelimumab
- Rhabdomyolysis resulting from the interaction of rosuvastatin and abiraterone: A case study
- Dual alexithymia: A relational framework for clinical communication in oncology
- Refining MRI-guided surgical strategy for borderline low rectal cancer: Beyond baseline imaging and oncologic endpoints
- Pretreatment platelet count exhibits a U-shaped association with outcomes after immune checkpoint blockade with a mid-range stratum for dual-checkpoint immunotherapy
- Early pembrolizumab as salvage therapy in EMA-CO-refractory ultra-high-risk gestational choriocarcinoma
- The frozen section debate in head and neck cancer: evidence, limitations, and future directions
- No recurrent severe immune-related hepatitis during PD-L1 therapy after PD-1-related hepatitis in advanced gastroesophageal junction adenocarcinoma: a case report